1st A news will be hard to figure/predict. The gov has deep pockets (our money). FDA does not care to lose. Inclined to take everything to the limit. US attny is on salary, Has to do SOMETHING all day. Private attorney would take the client's money. $'s take sting out of loss. But gov attny's live by their rep. They do not not care to lose either. But case is a losing case. Preliminary (got a buddy who's a big time business law attny) action says, "Don't make me sit through this. We KNOW where this is going. You guys figure this out." Stakes are huge for AMRN, steep for FDA in terms of precedent and eroding authority. Number of clear paths. And a lot of conflicting incentives. My bet is agree to disagree and a trial. Ands that is not bad for AMRN. They can continue to sell and the path gets steeper for the FDA.
News 
Market Data 
Discover 
